AzTrials
AzTrials

Infection, Surgical SiteNCT03659344

Efficacy of Antimicrobial Coating Suture Coated Vicryl Plus Compared With Vicryl in Reduced Surgical Site Infection of Dental Implant Surgeries: A Uni-Blind Randomized Clinical Trial Study

A study testing Vicryl plus in people with Infection, Surgical Site, run by Shiraz University of Medical Sciences.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients randomly aligned in 2 groups.Vicryl plus sutures were used in group 1 for closing subperiostal flaps after dental implant surgeries and vicryl sutures were used in group 2. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Infection, Surgical Site
What is being tested?
Vicryl plus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
320 participants
Where
No sites listed yet
Study dates
1 Sep 2016to 30 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Need 3 dental implants at the posterior of the mandible

Who cannot join

  • Diabetic patients
  • smoker
  • poor oral hygiene

About this study

Official title: Vicryl Plus and Vicryl Sutures in Reduce of Infection in Dental Implant Surgery

Patients randomly aligned in 2 groups.Vicryl plus sutures were used in group 1 for closing subperiostal flaps after dental implant surgeries and vicryl sutures were used in group 2.

Read the detailed description

Patients were divided randomly based on computer randomization list in two groups: In group1, vicryl plus 4-0 (Vicryl Plus Ethicon,Johnson \& Johnson Company, Sommerville, NJ) suture was used to close surgical site and Vicryl 4-0 (Vicryl Ethicon,Johnson \& Johnson Company, Sommerville, NJ) in group II.

All dental implants were placed through creating subperiosteal flaps. In each group, fresh socket placed dental implants were documented. Patients were visited in 1, 2, 3 and 4 weeks after dental implant surgeries.

Postoperative infection was defined as local erythematous change in the sutured wound with purulent discharge or localized abscess formation on surgical site. If wound dehiscence occurred, it was documented.

Patients were blind about what suture was used.

Being tested
Vicryl plus
Keywords
sutures, Surgical Wound Infection, Polyglactin 910
Medical subject headings
Surgical Wound Infection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vicryl plusDrug

    Using vicryl sutures which coated with triclosan (antibiotic)

Study groups in NCT03659344
Study groupRoleWhat they receive
Vicryl plusActive comparatorIn this group, vicryl plus(Triclosan coated) sutures were used to close flaps
Receives: Drug: Vicryl plus
vicrylNo interventionIn this group, vicryl sutures were used to close flaps

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The prevalence of post-operative infection

    The number of participants who had local erythematous change in the sutured wound with purulent discharge or localized abscess formation on surgical site.

    Measured: In one month

  2. The prevalence of post-operative dehiscence

    The number of participants who had relatively or completely open wound

    Measured: In one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2018
  2. Study start1 Sep 2016
  3. Primary completion1 Feb 2018
  4. Study completion30 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
In group1, vicryl plus suture was used to close flaps. In group2,vicryl was used to close flaps
Masking
Single blind
Who is masked
Participant
Enrolment
320 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03659344
Sponsor's protocol ID
IR.SBMU.RIDS.REC.1395.336
Status last verified
Sep 2018
First submitted
31 Aug 2018
Last updated
6 Sep 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Vicryl plus in people with Infection, Surgical Site, run by Shiraz University of Medical Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The prevalence of post-operative infection (time frame: In one month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in